Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bhagyalaxmi Sukka Ganesh"'
Autor:
Arun J. Sanyal, Phillip B. Hylemon, Bhagyalaxmi Sukka Ganesh, Huiping Zhou, Guanhua Lai, Derrick Zhao, William M. Pandak, Zhiming Huang, Jasmohan S. Bajaj, Xiaojiaoyang Li, Runping Liu
Publikováno v:
Hepatology. 67:1441-1457
Impaired intestinal barrier function promotes the progression of various liver diseases including cholestatic liver disease. The close association of primary sclerosing cholangitis (PSC) with inflammatory bowel disease highlights the importance of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe7fd14c4fda23c80f29f9fe0e6676f0
https://doi.org/10.1002/hep.29540
https://doi.org/10.1002/hep.29540
Publikováno v:
The Journal of Immunology. 196:202.10-202.10
Innate immune cells, such as macrophages (MΦ), play a critical role in the initiation and duration of inflammatory responses directed against foreign pathogens. The elaboration of immune effector by MΦ are coordinated by interactions of microbial s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b690264cbcbbcaf639b2e9e4c1bcd04c
https://doi.org/10.4049/jimmunol.196.supp.202.10
https://doi.org/10.4049/jimmunol.196.supp.202.10
Autor:
Najmunnisa Nasreen, Michael A. Jantz, Nazli Khodayari, Eugene P. Goldberg, Bhagyalaxmi Sukka-Ganesh, Kamal A. Mohammed
Publikováno v:
D14. ADVANCES IN PLEURAL INFECTION AND MALIGNANCY.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5df0e2fca17cb897974de7680c91429f
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5338
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5338
Autor:
Nazli Khodayari, Bhagyalaxmi Sukka-Ganesh, Sriram Peruvemba, Zita Burkhalter, Kamal A. Mohammed, Lixandra Gonzalves, Najmunnisa Nasreen
Publikováno v:
A101. PHARMACOLOGICAL TREATMENT OF COPD: OLD AND NEW.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dd31cebcbb7d11e77a09d1e29f82755
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2278
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2278
Autor:
Eugene P. Goldberg, Bhagyalaxmi Sukka-Ganesh, Kamal A. Mohammed, Nazli Khodayari, Najmunnisa Nasreen
Publikováno v:
D74. MOLECULAR TARGETS AND MODEL THERAPIES FOR LUNG CANCER.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bfa77ea8220e6d105a1a853b4450d23
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6290
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6290
Autor:
Nazli Khodayari, Sriram Peruvemba, Bhagyalaxmi Sukka-Ganesh, Kamal A. Mohammed, Najmunnisa Nasreen
Publikováno v:
International immunopharmacology. 12(1)
Fluticasone propionate (FP) and Salmeterol (SAL) are commonly used in combination therapy for patients with Chronic obstructive pulmonary disease (COPD). Clinical studies show that FP/SAL used in combination therapy was found to inhibit airway inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0bdc74584c2309dfce03d80b7379ee4
https://pubmed.ncbi.nlm.nih.gov/22155101
https://pubmed.ncbi.nlm.nih.gov/22155101
Publikováno v:
The Journal of Immunology. 194:121.2-121.2
Systemic Lupus erythematosus (SLE) is a chronic inflammatory autoimmune disorder with unknown etiology. Given the importance of the suppressor of cytokine signaling (SOCS) family of intracellular proteins in the regulation of lupus promoting cytokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0e76cc28b15bc5fe35f2baa54456db3
https://doi.org/10.4049/jimmunol.194.supp.121.2
https://doi.org/10.4049/jimmunol.194.supp.121.2
Publikováno v:
Cancer Research. 73:5346-5346
Introduction: Receptor EphA2 is over expressed in NSCLC and is associated with tumor progression and poor survival. MicroRNAs (miRs) are short, non-coding RNAs that post-transcriptionally regulate gene expression. Dysregulated expression of miRs has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8740e994a9973d79bd37cd215f3ff8e
https://doi.org/10.1158/1538-7445.am2013-5346
https://doi.org/10.1158/1538-7445.am2013-5346
Autor:
Najmunnisa Nasreen, Eugene P. Goldberg, Frederic J. Kaye, Bhagyalaxmi Sukka-Ganesh, Kamal A. Mohammed
Publikováno v:
BMC Cancer
BMC Cancer, Vol 12, Iss 1, p 309 (2012)
BMC Cancer, Vol 12, Iss 1, p 309 (2012)
Background Tumor formation is a complex process which involves constitutive activation of oncogenes and suppression of tumor suppressor genes. Receptor EphA2 and its ligand ephrin-A1 form an important cell communication system with its functional rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6aa1d83832d6bf5ed6b3651f33fdb8
http://europepmc.org/articles/PMC3488573
http://europepmc.org/articles/PMC3488573
Publikováno v:
Cancer Research. 72:3073-3073
Introduction: Ephrin-A1 ligand exerts anti-oncogeneic effect in NSCLC tumor cells through activation and down regulation of the EphA2 receptor. Alteration in their expression levels is associated with aggressive tumor growth. The underlying mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba3270e2a7d9cd877d3abe1d7273d17
https://doi.org/10.1158/1538-7445.am2012-3073
https://doi.org/10.1158/1538-7445.am2012-3073